Dr. Mayur Narkhede, MD
Claim this profileUniversity of Alabama at Birmingham
Studies Lymphoma
Studies Lymphoid Leukemia
4 reported clinical trials
5 drugs studied
Area of expertise
1Lymphoma
CD20 positive
CD5 positive
CD23 positive
2Lymphoid Leukemia
CD20 positive
CD5 positive
CD23 positive
Affiliated Hospitals
Clinical Trials Mayur Narkhede, MD is currently running
Loncastuximab + Acalabrutinib
for Chronic Lymphocytic Leukemia
Study is a phase I study to determine the maximum tolerated dose of adding Loncastuximab Tesirine to Aclabrutinib in the treatment of chronic lymphocytic leukemia.
Recruiting1 award Phase 19 criteria
Siltuximab
for CRS and ICANS Related to CAR-T Therapy
This study will evaluate the use of siltuximab to decrease the severity of cytokine release syndrome (CRS) and immune effector cell-associated neurological syndrome (ICANS) in patients who will receive chimeric antigen receptor (CAR) T-cell therapy for the treatment of hematological malignancies.
Recruiting1 award Phase 29 criteria
More about Mayur Narkhede, MD
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mayur Narkhede, MD has experience with
- Acalabrutinib
- Loncastuximab Tesirine
- Siltuximab
- CLN-978
- Tazemetostat
Breakdown of trials Mayur Narkhede, MD has run
Lymphoid Leukemia
Non-Hodgkin's Lymphoma
T-Lymphoblastic Leukemia/Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mayur Narkhede, MD specialize in?
Mayur Narkhede, MD focuses on Lymphoma and Lymphoid Leukemia. In particular, much of their work with Lymphoma has involved CD20 positive patients, or patients who are CD5 positive.
Is Mayur Narkhede, MD currently recruiting for clinical trials?
Yes, Mayur Narkhede, MD is currently recruiting for 3 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Mayur Narkhede, MD has studied deeply?
Yes, Mayur Narkhede, MD has studied treatments such as Acalabrutinib, Loncastuximab Tesirine, Siltuximab.
What is the best way to schedule an appointment with Mayur Narkhede, MD?
Apply for one of the trials that Mayur Narkhede, MD is conducting.
What is the office address of Mayur Narkhede, MD?
The office of Mayur Narkhede, MD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35294 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.